UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Scandinavian journal of rheumatology, 2015-11, Vol.44 (6), p.449-455

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study

Annals of the rheumatic diseases, 2005-01, Vol.64 (1), p.130-133

2005

Link zum Volltext

Verfügbarkeit prüfen

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience

Rheumatology international, 2006-06, Vol.26 (8), p.741-748

2006

Link zum Volltext

Verfügbarkeit prüfen

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial

Scandinavian journal of rheumatology, 2007-01, Vol.36 (4), p.270-277

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

The Lancet (British edition), 1999-05, Vol.353 (9164), p.1568-1573

1999

Link zum Volltext

Verfügbarkeit prüfen

PMS83 - Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Value in health, 2015-11, Vol.18 (7), p.A648-A648

2015

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Value in health, 2015-11, Vol.18 (7), p.A648-A648

2015

Link zum Volltext

Verfügbarkeit prüfen

Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids

Journal of pharmaceutical analysis, 2017-12, Vol.7 (6), p.365-373

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

The Lancet (British edition), 1999-05, Vol.353 (9164), p.1568

1999

Link zum Volltext

Verfügbarkeit prüfen

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Journal of controlled release, 2017-02, Vol.248, p.96-116

2017

Link zum Volltext

Verfügbarkeit prüfen

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology, 2018-03, Vol.10 (2), p.e1473-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations

European journal of pharmaceutics and biopharmaceutics, 2020-03, Vol.148, p.118-125

2020

Link zum Volltext

Verfügbarkeit prüfen

Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye

Medical hypotheses, 2017-06, Vol.103, p.5-9

2017

Link zum Volltext

Verfügbarkeit prüfen

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

International journal of cardiology, 2013-10, Vol.168 (3), p.2186-2194

2013

Link zum Volltext

Verfügbarkeit prüfen

3-Dimensionally ordered macroporous PEDOT ion-exchange resins prepared by vapor phase polymerization for triggered drug delivery: Fabrication and characterization

Electrochimica acta, 2018-04, Vol.269, p.560-570

2018

Link zum Volltext

Verfügbarkeit prüfen

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Annals of the rheumatic diseases, 2013-06, Vol.72 (6), p.851-857

2013

Link zum Volltext

Verfügbarkeit prüfen

Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome

European heart journal, 2010-11, Vol.31 (22), p.2791-2798

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term survival after hospitalization for acute heart failure — Differences in prognosis of acutely decompensated chronic and new-onset acute heart failure

International journal of cardiology, 2013-09, Vol.168 (1), p.458-462

2013

Link zum Volltext

Verfügbarkeit prüfen

Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation

Circulation (New York, N.Y.), 2003-10, Vol.108 (16), p.1924-1926

2003

Link zum Volltext

Verfügbarkeit prüfen

ZnO/PVP nanoparticles induce gelation in type I collagen

European polymer journal, 2016-02, Vol.75, p.399-405

2016

Link zum Volltext

Verfügbarkeit prüfen

Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS

Drug delivery and translational research, 2016-12, Vol.6 (6), p.763-770

2016

Link zum Volltext

Verfügbarkeit prüfen

Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery

Journal of drug delivery science and technology, 2017-08, Vol.40, p.142-156

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Annals of the rheumatic diseases, 2014-11, Vol.73 (11), p.1954-1961

2014

Link zum Volltext

Verfügbarkeit prüfen

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Blood, 2017-12, Vol.130, p.2875-2875

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(50)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(37)
Life Sciences & Biomedicine
(33)
Humans
(24)
Female
(19)
Male
(19)
Biological And Medical Sciences
(15)
Medical Sciences
(15)
Middle Aged
(13)
Aged
(12)
Adult
(11)
Follow-Up Studies
(9)
Rheumatology
(9)
Cardiology. Vascular System
(8)
Heart
(8)
Arthritis, Rheumatoid - Drug Therapy
(7)
Drug Therapy, Combination
(7)
Treatment Outcome
(7)
Antirheumatic Agents - Therapeutic Use
(6)
Cardiac & Cardiovascular Systems
(6)
Cardiovascular System & Cardiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial

Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial

PMS83 - Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Cost-Effectiveness of Biologics Compared to Conventional Disease-Modifying Antirheumatic Drugs for Treatment of Rheumatoid Arthritis in Finland

Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases

Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations

Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study

3-Dimensionally ordered macroporous PEDOT ion-exchange resins prepared by vapor phase polymerization for triggered drug delivery: Fabrication and characterization

Infliximab for 6 months added on combination therapy in early rheumatoid arthritis: 2-year results from an investigator-initiated, randomised, double-blind, placebo-controlled study (the NEO-RACo Study)

Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome

Long-term survival after hospitalization for acute heart failure — Differences in prognosis of acutely decompensated chronic and new-onset acute heart failure

Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation

ZnO/PVP nanoparticles induce gelation in type I collagen

Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS

Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery

Targeted treatment with a combination of traditional DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of a randomised clinical trial, the NEO-RACo trial

Results from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib

Idling for Decades: A European Study on Risk Factors Associated with the Delay Before a Narcolepsy Diagnosis

Suchergebnisse filtern